Comparative functional genomics of the acarbose producers reveals potential targets for metabolic engineering

The α-glucosidase inhibitor acarbose is produced in large-scale by strains derived from Actinoplanes sp. SE50 and used widely for the treatment of type-2 diabetes. Compared with the wild-type SE50, a high-yield derivative Actinoplanes sp. SE50/110 shows 2-fold and 3–7-fold improvement of acarbose yi...

Descripción completa

Detalles Bibliográficos
Autores principales: Xie, Huixin, Zhao, Qinqin, Zhang, Xin, Kang, Qianjin, Bai, Linquan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: KeAi Publishing 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6350373/
https://www.ncbi.nlm.nih.gov/pubmed/30723817
http://dx.doi.org/10.1016/j.synbio.2019.01.001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6350373/
https://www.ncbi.nlm.nih.gov/pubmed/30723817
http://dx.doi.org/10.1016/j.synbio.2019.01.001

Ejemplares similares